Publications by authors named "Rogier Klok"

Claim this Profile
L
Long-Term Mortality and Morbidity Impact on Patients with Pulmonary Arterial Hypertension (PAH) If Access to Sotatercept Is Delayed: A Simulation Model.
Adnan Alsumali, Vallerie McLaughlin, Jestinah Chevure, Rogier Klok, Wenjie Zhang

Adv Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and symptom concordance between patients and physicians in pulmonary arterial hypertension in the United States, Europe, and Japan.
R James White, Dario Vizza, Rogier Klok, Julia Harley, Mark Small

Respir Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of right heart catheterization to diagnose pulmonary arterial hypertension using least absolute shrinkage selection operator (LASSO) regression.
Carmine D Vizza, Rogier Klok, Mark Small, Giorgio Castellano, Julia Harley

Curr Med Res Opin· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).
Vallerie McLaughlin, Adnan Alsumali, Rongzhe Liu, Rogier Klok, Eliana C Martinez

Adv Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes in risk status in pulmonary arterial hypertension.
Habib Bouzina, Göran Rådegran, Oisin Butler, Roger Hesselstrand, Clara Hjalmarsson, Rogier Klok

ESC Heart Fail· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor outcome of patients with pulmonary arterial hypertension with insufficient response to phosphodiesterase-5 inhibitors alone or in combination with other specific therapy: a registry-based study.
Clara Hjalmarsson, Oisin Butler, Roger Hesselstrand, Katsiaryna Holl, Kjell Jansson, Rogier Klok

Pulm Circ· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of pneumonia among children and adults with chronic medical conditions in Germany.
Stephen I Pelton, Kimberly M Shea, Raymond A Farkouh, David R Strutton, Sebastian Braun, Rogier Klok

BMC Infect Dis· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".
Raymond A Farkouh, Cassandra Hall-Murray, Rogier M Klok, Betsy Hilton, Raul E Isturiz

Infect Dis Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising assessments of the epidemiological impact in The Netherlands of paediatric immunisation with 13-valent pneumococcal conjugate vaccine using dynamic transmission modelling.
Elisabetta De Cao, Alessia Melegaro, Rogier Klok, Maarten Postma

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor.
Rogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, Raymond A Farkouh, David R Strutton

Clin Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
Rogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, Raymond A Farkouh, David R Strutton

Clin Ther· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: economic evaluation of second generation pneumococcal conjugate vaccines in Norway.
Raymond Farkouh, Rogier Klok, Craig Roberts, Asbjørn Mack, David Strutton

Vaccine· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptions.
Raymond A Farkouh, Rogier M Klok, Maarten J Postma, Craig S Roberts, David R Strutton

Expert Rev Vaccines· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of 13-valent pneumococcal conjugate vaccine: Germany, Greece, and The Netherlands.
David R Strutton, Raymond A Farkouh, Stephanie R Earnshaw, Sharon Hwang, Ulrike Theidel, Rogier Klok

J Infect· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the Netherlands.
Cornelis Boersma, Rogier M Klok, Jasper M Bos, Mark Naunton, Paul B van den Berg

Appl Health Econ Health Policy· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in relation to constipation among opioid users.
Fernie J A Penning-van Beest, Pieter van den Haak, Rogier M Klok, Yves F D M Prevoo, Donald L van der Peet

J Med Econ· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study.
Harald E Vonkeman, Louise M A Braakman-Jansen, Rogier M Klok, Maarten J Postma, Jacobus R B J Brouwers

Arthritis Res Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: the impact of varying the discount rate for health.
Robin de Vries, Rogier M Klok, Jacobus R B J Brouwers, Maarten J Postma

Vaccine· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct medical costs of serious gastrointestinal ulcers among users of NSAIDs.
Harald E Vonkeman, Rogier M Klok, Maarten J Postma, Jacobus R B J Brouwers, Mart A F J van de Laar

Drugs Aging· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomics of quetiapine for the management of acute mania in bipolar I disorder.
Rogier M Klok, Asmar Fy Al Hadithy, Nathalie Pjt van Schayk, Ad Jj Antonisse, Jaime J Caro

Expert Rev Pharmacoecon Outcomes Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Rogier M Klok, Nicolaas L A Arents, Robin de Vries, Jacob C Thijs, Jacobus R B J Brouwers

Clin Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four quadrants of the cost-effectiveness plane: some considerations on the south-west quadrant.
Rogier M Klok, Maarten J Postma

Expert Rev Pharmacoecon Outcomes Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacoeconomics of gastrointestinal drug utilisation prior and post Helicobacter pylori eradication.
Rogier M Klok, Willem Jan van der Veen, Ger Th van der Werf, Paul B van den Berg, Jacobus R B J Brouwers

Helicobacter· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
Ben A van Hout, Rogier M Klok, Jacobus R B J Brouwers, Maarten J Postma

Clin Ther· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis